Single Oral Dose Comparative Bioavailability Study of Investigational Product in Healthy Human Subjects Under Fasting Conditions.

StatusCompleted
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Completed without a posted recruiting period Show 4 more changesShow less
    • Primary and study completion dates changed from estimate of Nov 1, 2025 to Oct 7, 2025
    • Start date changed from estimate of Sep 1, 2025 to Sep 15, 2025
    • Eligibility criteria expanded, about 135 words
    • Site contact updated
  2. Minor Study First Submitted
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The sponsor has developed new curcuminoid formulations with the expectation of enhanced bioavailability compared to existing benchmark products. This study aims to evaluate the comparative bioavailability and characterize the pharmacokinetic profile of the test formulations in comparison to the reference formulations in healthy adult subjects under fasting conditions.
Trial Details
NCT Number NCT07141368
Lead Sponsor Vedic Lifesciences Pvt. Ltd.
Conditions
(from sponsor)
Healthy Volunteer
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov